International Pharmaceutical Expo (INTERPHEX), the premier event dedicated to pharmaceutical and biotechnology innovation, technology and knowledge from development through commercialization, and the Parenteral Drug Association (PDA), a leading provider of science, technology and regulatory information and education, announced a three-year Premium Association Sponsorship agreement and the introduction of PDA Roundtable Discussions at the show.
INTERPHEX, which takes place March 21-23, 2017 at the Javits Center in New York, offers access to technical sessions, cutting-edge development, manufacturing technologies, and innovation to cost effectively and efficiently develop and manufacture quality product.
“We are delighted to continue our relationship with PDA,” said Melissa Ashley, Senior Vice President, INTERPHEX. “Partnering with PDA aligns us with key industry thought leaders and enhances the opportunities for our attendees to learn and source cutting-edge solutions from leading industry suppliers in order to cost effectively develop and manufacture quality product.
“PDA’s commitment to developing scientifically sound, practical technical information and expertise to advance pharmaceutical / biopharmaceutical manufacturing science and regulation is in perfect alignment with the INTERPHEX mission and the needs of our customers,” Ashley added. “This partnership helps support INTERPHEX as the industry forum ‘Where the Industry Comes Together‘.”
Richard Johnson, President and CEO, PDA, said: “There is a strong commitment from both organizations to deliver state-of-the-art insight, innovation and technical expertise for the benefit of industry professionals worldwide. We are delighted to continue our collaboration with INTERPHEX as the Premier Association Sponsor. We are pleased to move forward in this shared commitment to the industry.”
PDA will debut a new, no cost learning opportunity, PDA Roundtable Discussions, at INTERPHEX 2017. Led by industry experts and technical report authors, the roundtables offer informative discussions and updates on important industry topics and related PDA technical reports, including Blow Fill Seal technology (newly released PDA Technical Report 77), pharmaceutical glass handling, and nonconformities related to elastomeric closures and aluminum seals. All three Discussions will debut on Tuesday, March 21, 2017 and repeat on Wednesday, March 22, 2017.
PDA Roundtable Discussion Schedule
Blow Fill Seal (BFS) Roundtable
Tuesday, March 21, 9:00am-10:00am / Wednesday, March 22, 1:00pm-2:00pm
An interactive discussion on what factors should be considered in BFS machine selection and facility setup based upon product requirements and aspects of proper process validation.
Moderators: Martin Haerer, Rommelag; Tim Kram, Rommelag; Patrick Poisson, United Therapeutics
Pharmaceutical Glass Handling Roundtable
Tuesday, March 21, 11:00am-12:00pm / Wednesday, March 22, 11:00am-12:00pm
Packaging industry experts lead an interactive discussion, separating fact from myth, on what factors may influence the amount of glass breakage during processes ranging from receipt and washing to fill and packaging.
Moderators: Jim Nadlonek, Bausch+Strobel; Tony Perry, Schott North America
Nonconformities in Elastomeric Closures and Aluminum Seals for Parenteral Packaging Roundtable
Tuesday, March 21, 1:00pm-2:00pm / Wednesday, March 22, 9:00am -10:00am
Discuss issues with classification of nonconformities related to elastomeric closures and aluminum seals, areas of improvements between pharma and suppliers as well as opportunities to improve collaborative efforts to meet regulatory requirements.
Moderators: Andrea Straka, West Pharmaceuticals